{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:39:19Z","timestamp":1761665959977,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jogc.2017.11.021","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T22:42:08Z","timestamp":1519944128000},"page":"896-902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incidence and Carrier Frequency of CFTR Gene Mutations in Pregnancies With Echogenic Bowel in Nova Scotia and Prince Edward Island"],"prefix":"10.1016","volume":"40","author":[{"given":"Michelle E.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria M.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo-Ann K.","family":"Brock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2017.11.021_bib0010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.35.8.657","article-title":"Cystic fibrosis screening: a fetus with hyperechogenic bowel may be the index case","volume":"35","author":"Muller","year":"1998","journal-title":"J Med Genet"},{"key":"10.1016\/j.jogc.2017.11.021_bib0015","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00006250-199912000-00021","article-title":"Predicting the risk of cystic fibrosis with echogenic fetal bowel and one cystic fibrosis mutation","volume":"94","author":"Bosco","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.021_bib0020","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1067\/mob.2001.117671","article-title":"The clinical significance of fetal echogenic bowel","volume":"185","author":"Al-Kouatly","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.021_bib0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/pd.787","article-title":"Follow-up of children with isolated fetal echogenic bowel with particular reference to bowel-related symptoms","volume":"24","author":"Patel","year":"2004","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.11.021_bib0030","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3109\/14767050903551442","article-title":"Outcomes for fetal echogenic bowel during the second trimester ultrasound","volume":"23","author":"Iruretagoyena","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2017.11.021_bib0035","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ajog.2010.08.033","article-title":"Focus on cystic fibrosis and other disorders evidenced in fetuses with sonographic finding of echogenic bowel: 16-year report from Brittany, France","volume":"203","author":"Scotet","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.021_bib0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00439-010-0933-1","article-title":"Comprehensive description of CFTR genotypes and ultrasound patterns in 694 cases of fetal bowel anomalies: a revised strategy","volume":"129","author":"de Becdelievre","year":"2011","journal-title":"Hum Genet"},{"key":"10.1016\/j.jogc.2017.11.021_bib0045","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/AOG.0b013e31821aa739","article-title":"Echogenic bowel on second-trimester ultrasonography: evaluating the risk of adverse pregnancy outcome","volume":"117","author":"Goetzinger","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.11.021_bib0050","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1136\/jmg.2003.015065","article-title":"Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR mutation","volume":"41","author":"Ogino","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.jogc.2017.11.021_bib0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.GIM.0000162871.68167.8A","article-title":"Risk calculations for cystic fibrosis in neonatal screening by immunoreactive trypsinogen and CFTR mutation tests","volume":"7","author":"Ogino","year":"2005","journal-title":"Genet Med"},{"key":"10.1016\/j.jogc.2017.11.021_bib0060","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00125817-200209000-00010","article-title":"Standards and guidelines for CFTR mutation testing","volume":"4","author":"Richards","year":"2002","journal-title":"Genet Med"},{"key":"10.1016\/j.jogc.2017.11.021_bib0070","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jogc.2017.11.021_bib0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000336123","article-title":"Perinatal outcomes following the ultrasound diagnosis of echogenic bowel: an Australian perspective","volume":"31","author":"Ameratunga","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogc.2017.11.021_bib0085","doi-asserted-by":"crossref","first-page":"F256","DOI":"10.1136\/archdischild-2012-302017","article-title":"Outcomes of infants presenting with echogenic bowel in the second trimester of pregnancy","volume":"98","author":"Buiter","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.jogc.2017.11.021_bib0090","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(98)70344-0","article-title":"The diagnosis of cystic fibrosis: consensus statement. Cystic Fibrosis Foundation Consensus Panel","volume":"132","author":"Rosenstein","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jogc.2017.11.021_bib0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3476(98)70441-X","article-title":"Comparison of the clinical manifestations of cystic fibrosis in black and white patients","volume":"132","author":"Hamoush","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jogc.2017.11.021_bib0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1053\/j.gastro.2010.10.045","article-title":"Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis","volume":"140","author":"Schneider","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jogc.2017.11.021_bib0105","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/gutjnl-2011-300645","article-title":"CFTR, SPINK1, CTRC and PRSS1 variants in chronic pancreatitis: is the role of mutated CFTR overestimated?","volume":"62","author":"Rosendahl","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jogc.2017.11.021_bib0110","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/GIM.0b013e31818e55a2","article-title":"Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders","volume":"10","author":"Moskowitz","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.jogc.2017.11.021_bib0115","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMoa051469","article-title":"Genetic modifiers of lung disease in cystic fibrosis","volume":"53","author":"Drumm","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2017.11.021_bib0120","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1164\/rccm.200608-1164OC","article-title":"Heritability of lung disease severity in cystic fibrosis","volume":"175","author":"Vanscoy","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jogc.2017.11.021_bib0125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jama.299.4.417","article-title":"Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease","volume":"299","author":"Collaco","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2017.11.021_bib0130","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201009-1478CI","article-title":"Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life","volume":"183","author":"Cohen-Cymberknoh","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jogc.2017.11.021_bib0135","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ajpath.2014.12.022","article-title":"New insights about miRNAs in cystic fibrosis","volume":"185","author":"Sonneville","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jogc.2017.11.021_bib0140","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.stem.2013.10.016","article-title":"Correction of a genetic disease in mouse via use of CRISPR-Cas9","volume":"13","author":"Wu","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jogc.2017.11.021_bib0145","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1378\/chest.13-2397","article-title":"Effects of ivacaftor in patients with cystic fibrosis who carry the G551D mutation and have severe lung disease","volume":"146","author":"Barry","year":"2014","journal-title":"Chest"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S170121631730796X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S170121631730796X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:32:02Z","timestamp":1761665522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S170121631730796X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S170121631730796X"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2017.11.021","relation":{},"ISSN":["1701-2163"],"issn-type":[{"type":"print","value":"1701-2163"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Carrier Frequency of CFTR Gene Mutations in Pregnancies With Echogenic Bowel in Nova Scotia and Prince Edward Island","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2017.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}